Iproniazid
An irreversible inhibitor of monoamine oxidase types A and B that is used as an antidepressive agent. It has also been used as an antitubercular agent, but its use is limited by its toxicity.
Also Known As:
Iprazid; 4-Pyridinecarboxylic acid, 2-(1-methylethyl)hydrazide
Networked: 203
relevant articles (1 outcomes,
8 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Experts
1. | Juli, Luigi:
1 article
(11/2014)
|
2. | Juli, Alfredo:
1 article
(11/2014)
|
3. | Howland, Robert H:
1 article
(10/2010)
|
4. | López-Muñoz, Francisco:
1 article
(01/2009)
|
5. | Alamo, Cecilio:
1 article
(01/2009)
|
6. | Thijssen-Vanzuylen, Carol:
1 article
(07/2007)
|
7. | Tas, Albert C:
1 article
(07/2007)
|
8. | Mellema, Jan-Remt:
1 article
(07/2007)
|
9. | Vogels, Jack T W E:
1 article
(07/2007)
|
10. | Zandberg, Pieter:
1 article
(07/2007)
|
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures